Ribosomal Protein L24 inhibitors are a class of chemical compounds that specifically target and disrupt the function of Ribosomal Protein L24 (RPL24), a key component of the large subunit of the ribosome. RPL24 plays a crucial role in the early stages of ribosome assembly and is involved in stabilizing the structure of the ribosome during the process of protein synthesis. Positioned at the interface between the ribosomal RNA (rRNA) and various ribosomal proteins, RPL24 facilitates the proper folding and alignment of rRNA, ensuring the functional integrity of the ribosome. Inhibitors of RPL24 typically act by binding to critical regions of the protein, hindering its interaction with rRNA or other essential components of the ribosome, which can compromise the assembly and functionality of the ribosome.
The inhibition of RPL24 can lead to profound effects on the ribosome's ability to synthesize proteins efficiently, particularly by interfering with the initiation phase of translation, where ribosome assembly is most critical. By preventing the proper formation of the ribosomal subunits, these inhibitors disrupt the machinery responsible for protein production, leading to a reduction in the overall capacity for translation within the cell. Ribosomal Protein L24 inhibitors are important tools in molecular biology, allowing researchers to dissect the specific role of RPL24 in ribosomal biogenesis and function. They provide insight into how individual ribosomal proteins contribute to the overall architecture and operation of the ribosome. Additionally, these inhibitors are valuable for exploring the evolutionary conservation of ribosomal components across species, as they can reveal how structural differences in ribosomes affect protein synthesis in different organisms. Through the targeted inhibition of RPL24, researchers can gain a deeper understanding of the molecular mechanisms underlying ribosome assembly and translational regulation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D inhibits RNA synthesis by binding to DNA, blocking RNA polymerase from attaching to the DNA strand. This could lead to reduced expression of RPL24. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits protein synthesis by blocking translation elongation, which could indirectly affect the synthesis of RPL24. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a kinase involved in cell growth and proliferation. Inhibition of mTOR could reduce the expression of proteins like RPL24. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Puromycin causes premature chain termination during translation, affecting protein synthesis including that of RPL24. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
An antimetabolite that inhibits RNA synthesis, which could reduce the expression of ribosomal proteins like RPL24. | ||||||
Azithromycin | 83905-01-5 | sc-254949 sc-254949A sc-254949B sc-254949C sc-254949D | 25 mg 50 mg 500 mg 1 g 5 g | $52.00 $103.00 $260.00 $364.00 $728.00 | 17 | |
Azithromycin binds to the 50S ribosomal subunit, potentially affecting the association and function of ribosomal proteins like RPL24. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide inhibits DNA synthesis and could indirectly affect the expression of RPL24 by affecting cellular replication and transcription processes. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Mitomycin C crosslinks DNA, disrupting DNA synthesis and transcription, which could inhibit the expression of RPL24. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin inhibits protein synthesis by affecting peptide bond formation, potentially inhibiting RPL24 synthesis. | ||||||
Chloramphenicol | 56-75-7 | sc-3594 | 25 g | $90.00 | 10 | |
Chloramphenicol inhibits protein synthesis by preventing peptide bond formation, affecting the synthesis of proteins like RPL24. | ||||||